Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Spotlight

Set Alert for Start-Up Spotlight

Start-Up Spotlight: BioIntelliSense Launches New FDA-Cleared BioSticker For Remote Monitoring Of Patients' Vital Signs

BioIntelliSense is getting ready to trial its newly FDA-cleared BioSticker in patients at Colorado-based hospital network UCHealth for remote monitoring of vital signs.

Start-up Spotlight Digital Health StartUps and SMEs

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.

Commercial Innovation

QUOTED. 25 February 2020. David Maman.

Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.   

Quoted StartUps and SMEs

Start-Up Spotlight: 'Cheeky Tech' – How Binah.Ai Uses Math, Plethysmography And AI To Extract Vital Signs From A Person's Cheeks

Israel-based start-up Binah.ai plans to file for US FDA approval of its video-based monitoring app that can detect vital signs in seconds with a simple scan of a person's cheeks.

Start-up Spotlight StartUps and SMEs

QUOTED. 11 February 2020. Jim Mault.

This quarter, Denver, CO-based start-up BioIntelliSense and its strategic partner, UCHealth, will begin clinical testing of the BioSticker, a wearable sensor designed to remotely monitor patients' vital signs that was recently cleared by the US Food and Drug Administration. See what BioIntelliSense's founder and CEO, Jim Mault, said about it here.

Quoted Start-up Spotlight

Start-Up Spotlight: BioIntelliSense Launches New FDA-Cleared BioSticker For Remote Monitoring Of Patients' Vital Signs

BioIntelliSense is getting ready to trial its newly FDA-cleared BioSticker in patients at Colorado-based hospital network UCHealth for remote monitoring of vital signs.

Start-up Spotlight Digital Health

Start-Up Spotlight: BioVentrix Expects Revivent TC Heart Failure Device To Succeed Where Others Failed

Two-year data from a European trial showed BioVentrix’s Revivent TC system significantly reduces left-ventricular volume and improves left-ventricular function in patients with heart failure following a myocardial infarction. The company expects to complete a US pivotal trial of the device in 2021 and launch the device in the US with funding from a planned initial public offering.

Start-up Spotlight Innovation
See All
UsernamePublicRestriction

Register